🤝 Arianna Huffington and Sam Altman Team Up

Plus:ITRC reported 118% increase in job scams

Together with

In today's email

  1. 📲 Arianna Huffington and Sam Altman Team Up to Launch Thrive AI Health

  2. 🤖 Fortune Favors The Bold 

  3. 👊 Job Scams Surge by 118% in 2023 Due to AI-Enhanced Tactics

  4. 🤯 Quick Takes

Read Time: 5 Minutes

In the Know

Arianna Huffington and Sam Altman Team Up to Launch Thrive AI Health

Image: Arianna Huffington/Michael Buckner—Getty Images

Arianna Huffington's Thrive Global and Sam Altman's OpenAI Startup Fund have partnered to launch Thrive AI Health, a startup focused on developing AI-powered health coaching technology to promote healthier lifestyles and address health inequities.

Key Points

  • Thrive AI Health aims to democratize access to expert-level health coaching to improve health outcomes and tackle chronic diseases.

  • The AI health coach will provide personalized advice on sleep, food, fitness, stress management, and connection using generative AI.

  • The startup is funded by the OpenAI Startup Fund, Thrive Global, and the Alice L. Walton Foundation.

  • Research partnerships include Stanford Medicine, the Alice L. Walton School of Medicine, and the Rockefeller Neuroscience Institute at West Virginia University.

  • The goal is to improve health outcomes, reduce healthcare costs, and significantly impact chronic diseases worldwide through proactive, multimodal, expert-level coaching.

Thrive AI Health represents a groundbreaking approach to health management by leveraging AI to provide personalized, data-driven health coaching. With robust backing, strategic partnerships, and a mission to address chronic diseases and health inequities, Thrive AI Health aims to revolutionize how individuals manage their health and wellness.

Fortune Favors The Bold

Ever wish you could turn back time and invest in Amazon's early days? Well, buckle up because the AI revolution is offering a second chance.Ever wish you could turn back time and invest in Amazon's early days? Well, buckle up because the AI revolution is offering a second chance. In The Motley Fool's latest report, dive into the world of AI-powered innovation. Discover why experts are calling it "the rocket fuel of AI" and predicting a market cap nine times larger than Amazon's.

Don't let past regrets hold you back. Take charge of your future and capitalize on the AI wave with The Motley Fool's exclusive report. Whether it's AI or Amazon, fortune favors the bold.

Job Scams Surge by 118% in 2023 Due to AI-Enhanced Tactics

The Identity Theft Resource Center (ITRC) reported a 118% increase in job scams in 2023 compared to the previous year, despite an 18% decrease in overall scam reports. This rise in job scams is attributed to identity thieves using generative artificial intelligence to create legitimate-looking job postings on reputable sites. Scammers created professional profiles and websites, often impersonating real companies, and moved interviews off-platform to collect sensitive personal information from applicants, such as Social Security numbers and direct deposit details. Victims typically realized they were scammed only after sharing their information and experiencing communication delays or being asked for login details to ID.me. The ITRC emphasized that while AI tools enhance scam tactics, the best defense remains simple: verifying contacts directly by phone.

Quick Takes

  • US Disrupts Russian AI-Powered Disinformation Campaign: The US government thwarted a Russian disinformation effort that used AI-powered bots to create fake social media profiles on X, officials announced. Nearly 1,000 accounts, part of a bot farm developed by a Russian state media editor and funded by the FSB, impersonated Americans and promoted pro-Russian messaging, leading to their suspension for violating X's terms of service.

  • AI Tool Designs New Proteins That Could Transform Medicine: EvolutionaryScale's AI model, ESM3, has been used to create new fluorescent molecules, demonstrating the potential of AI in protein design. The company, founded by former Meta scientists, received $142 million in funding to further develop applications in drug development, sustainability, and more. ESM3, a protein language model trained on over 2.7 billion protein sequences, is poised to revolutionize biological research and medicine with its ability to generate novel proteins based on user specifications.